These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23434145)

  • 21. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy.
    Yang Q; Sakurai T; Yoshimura G; Suzuma T; Umemura T; Nakamura M; Nakamura Y; Mori I; Kakudo K
    Oncol Rep; 2003; 10(1):121-5. PubMed ID: 12469156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.
    Wazir U; Jiang WG; Yasaei H; Linne H; Newbold RF; Mokbel K
    Anticancer Res; 2013 May; 33(5):2185-9. PubMed ID: 23645774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.
    Koo JS; Jung W; Jeong J
    Jpn J Clin Oncol; 2009 Sep; 39(9):560-8. PubMed ID: 19531543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
    Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
    Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
    IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples.
    Arihiro K; Oda M; Ogawa K; Tominaga K; Kaneko Y; Shimizu T; Matsumoto S; Oda M; Kurita Y; Taira Y
    Jpn J Clin Oncol; 2013 Jan; 43(1):55-62. PubMed ID: 23225912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
    Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
    Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
    Loibl S; Müller BM; von Minckwitz G; Schwabe M; Roller M; Darb-Esfahani S; Ataseven B; du Bois A; Fissler-Eckhoff A; Gerber B; Kulmer U; Alles JU; Mehta K; Denkert C
    Breast Cancer Res Treat; 2011 Nov; 130(2):477-87. PubMed ID: 21837479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of phosphorylated c-Jun NH2-terminal kinase in basal-like and "triple-negative" breast cancers.
    Wang X; Chao L; Li X; Ma G; Chen L; Zang Y; Zhou G
    Hum Pathol; 2010 Mar; 41(3):401-6. PubMed ID: 19913278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
    Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
    Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
    Philippin-Lauridant G; Baranzelli MC; Samson C; Fournier C; Pinte S; Mattot V; Bonneterre J; Soncin F
    Int J Oncol; 2013 Apr; 42(4):1367-75. PubMed ID: 23404186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.
    Collie-Duguid ES; Sweeney K; Stewart KN; Miller ID; Smyth E; Heys SD
    Breast Cancer Res Treat; 2012 Apr; 132(3):807-18. PubMed ID: 21695460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordance with local guidelines for adjuvant chemotherapy in breast cancer: reasons and effect on survival.
    Chéreau E; Coutant C; Gligorov J; Lesieur B; Antoine M; Daraï E; Uzan S; Rouzier R
    Clin Breast Cancer; 2011 Mar; 11(1):46-51. PubMed ID: 21421522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy is precise after primary systemic therapy in stage II-III breast cancer patients.
    Reitsamer R; Menzel C; Glueck S; Rettenbacher L; Weismann C; Hutarew G
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():286-90. PubMed ID: 20853048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
    Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
    Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between IL-10 expression and prognosis in patients with primary breast cancer.
    Li Y; Gao P; Yang J; Yu H; Zhu Y; Si W
    Tumour Biol; 2014 Nov; 35(11):11533-40. PubMed ID: 25129439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.